Back to all Current clinical trials
Back to all Current clinical trials
Palekona - An oral treatment for Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disease of the large intestine. It causes painful swelling and redness in the digestive tract, which can lead to abdominal pain, ulcers in the large intestine, and/or diarrhoea. Current treatments that are available include medications that can reduce inflammation and relieve symptoms. Other supportive medications may control diarrhoea, relieve pain, or supplement your diet.
- Category
-
Trial status
Recruiting
-
Trial phase
Phase 2 Drug TrialEarly stage studies investigating efficacy and safety compared to standard therapies, as well as final dose determination in moderate sized patient cohorts.
- Registry listing
-
ERM Project ID
92016
Trial contact details
-
Contact person
Sharyn Grossman
-
Phone
07 3163 8195
What you need to know
Who can take part?
- aged 18 - 75
- moderate to severely active UC
- UC diagnosed at least 3 months previously via endoscopy & histology
- previously treated by at least one prior therapy
- lab results in normal range at screening
Excluding:
- diagnosis with another bowel disorder
- pregnancy or breastfeeding
- likely known surgery during study period
- history of malignancy
- some mediations/medical history
What's involved for you?
- 18-20 study visits across 14 months
- Colonoscopy/Flexible Sigmoidoscopy x 3
- Blood tests x 18
- Urine tests
- ECG x 4
- Daily eDiary
- Questionnaires at study visits
- Oral (tablets) treatment
Trial Dates
March 2024 - August 2024
All research clinical trials news
-
News
Celebrating Excellence: Mater’s 2024 Publication of the Year Winners
-
News
Study aims to fight Inflammatory Bowel Disease with Aussie seafood
-
News
PhD student secures fellowship to pioneer mRNA vaccine for rare blood disorder
-
News
Clinical trials give hope to current and future breast cancer patients